{
  "id": "54d73e223706e89528000010",
  "type": "factoid",
  "question": "What is the generic name of Gliolan?",
  "ideal_answer": "5-aminolevulinic acid (or 5-ALA) is the generic name of Gliolan. It is approved for fluorescence-guided resections of adult malignant gliomas.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24468659",
    "http://www.ncbi.nlm.nih.gov/pubmed/22849976",
    "http://www.ncbi.nlm.nih.gov/pubmed/18389144",
    "http://www.ncbi.nlm.nih.gov/pubmed/25248327",
    "http://www.ncbi.nlm.nih.gov/pubmed/23870657"
  ],
  "snippets": [
    {
      "text": "BACKGROUND: Five-aminolevulinic acid (Gliolan, medac, Wedel, Germany, 5-ALA) is approved for fluorescence-guided resections of adult malignant gliomas. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25248327",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: This study evaluates the cost-effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan\u00ae) in patients undergoing surgery for malignant glioma, in standard clinical practice conditions in Spain. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24468659",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan(\u00ae)) in patients treated for malignant glioma under typical daily practice conditions in Spain, using complete resection rate (CR) and progression free survival at 6 months (PFS6). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23870657",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Today, ALA is approved as Levulan for actinic keratoses, the ALA-methyl ester Metvix for actinic keratoses and basal cell carcinoma, the ALA-hexyl ester Hexvix for the diagnosis of bladder cancer and Gliolan for malignant glioma. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18389144",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MATERIAL AND METHODS: All patients who had undergone 5-ALA fluorescence-guided surgery due to suspected malignant glioma were included. Patients received a standard preoperative dose of Gliolan. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22849976",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Today, ALA is approved as Levulan for actinic keratoses, the ALA-methyl ester Metvix for actinic keratoses and basal cell carcinoma, the ALA-hexyl ester Hexvix for the diagnosis of bladder cancer and Gliolan for malignant glioma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18389144",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "5-aminolevulinic acid"
}